vaccine alternatives
Invivyd Highlights Follow-Up to Pemgarda mAb Could Rival COVID Vaccines
Invivyd; Pemgarda; VYD2311; monoclonal antibody; COVID-19; vaccine alternatives; immune compromise; long-acting protection; phase 1/2 clinical data
Barinthus’ HPV Therapy Demonstrates Safety Yet Falls Short in Efficacy
Barinthus, HPV therapy, safety, efficacy, clinical trials, human papillomavirus, vaccine alternatives